Incannex Healthcare Inc. 8-K

What Happened
Incannex Healthcare Inc. (IXHL) filed a Form 8-K on January 22, 2026 (Item 8.01) announcing the formation of a Clinical Advisory Board to support its PSX-001 program. The company attached a press release dated January 22, 2026 as Exhibit 99.1 to the filing and incorporated that release by reference.

Key Details

• Filing date: January 22, 2026 (Form 8-K, Item 8.01).
• Event: Formation of a Clinical Advisory Board specifically for the PSX-001 program.
• Press release announcing the board is included as Exhibit 99.1 and is incorporated by reference in the 8-K.

Why It Matters
Creating a Clinical Advisory Board signals that Incannex is advancing the clinical development of PSX-001 and is seeking external medical and clinical expertise to guide trial design, strategy and related decisions. For investors, this is a development-stage operational update (not a financial result) that may affect the timeline and quality of future clinical milestones or regulatory interactions; the 8-K itself does not disclose board members, trial dates, or financial impacts.